STALLION Stallion India Fluorochemicals Q2 FY26 results (Jul–Sep 2025) and concall
Stallion India Fluorochemicals Ltd. reported robust Q2 and H1 FY26 results, with significant YoY growth in revenue, EBITDA, and PAT, exceeding 50% of its full-year revenue guidance. The company is making strategic progress on backward integration and capacity expansion with new facilities for R32 manufacturing and HFO refrigerants, despite a challenging macroeconomic environment and cyclical product markets. Management expressed confidence in achieving growth targets and expanding margins through these initiatives.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 55.9%, net profit up 1000.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 68 | 85 | 152 | 110 | 106 +56% |
| EBITDA | 2 | 14 | 19 | 14 | 16 +700% |
| Net profit | 1 | 10 | 13 | 10 | 11 +1000% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
